Federal Circuit To Rehear Patent Dispute Over On-Sale Bar In May
WASHINGTON, D.C. — In a March 11 order, the Federal Circuit U.S. Court of Appeals revealed that its rehearing of a patent dispute over the anti-coagulant drug bivalirudin will be reheard...To view the full article, register now.
Already a subscriber? Click here to view full article